Stocks · Health care · Pharmaceutical Preparations

Oruka Therapeutics, Inc.

ORKA Clue Score22

United States Fiscal year ends December CIK 0000907654 Results filed 10 Aug 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$340.07M

$2.72M on a plan · $336.57M straight out of an exercise

Sold at will

$777.00K

10 of 127 sales

Net

−$340.07M

−$777.00K against sales at will